CPNG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Coupang is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who is unwilling to wait for a better entry. The stock has valuation appeal only if the business recovery continues, but the current setup is still too weak: price trend is bearish, earnings were poor, analysts are cutting targets, and hedge funds are selling. I would not buy it today. The better call is to wait for signs of trend reversal and margin recovery.
CPNG is in a clear downtrend. MACD histogram is negative and still expanding lower, which shows downside momentum remains active. RSI_6 at 18.0 is oversold, but oversold alone is not a buy signal when trend structure is still bearish. The moving averages are stacked bearishly with SMA_200 > SMA_20 > SMA_5, confirming weakness across short, medium, and long horizons. Price at 17.34 is near the S1 support at 17.68 and above S2 at 16.72, so the stock is close to support but has not yet shown reversal strength. The next-day, next-week, and next-month pattern probabilities also lean negative.
Q1 2026 revenue increased 7.54% YoY to $8.504B, showing that top-line growth is still intact. News also notes nearly 80% recovery of WOW memberships lost after the prior data incident, which is a meaningful customer-recovery catalyst. Some analysts still maintain bullish or overweight views, and Barclays previously raised its target to $30 ahead of the Q1 report. The company may also benefit if operating recovery in Korea continues and Taiwan progress stays on track.
The latest quarter showed a net loss of -$266M and EPS of -0.15, both significantly worse YoY. Gross margin fell to 27.01%, down 7.78% YoY, which is the main concern because it points to profitability pressure. The stock dropped 13.7% after earnings, showing the market reacted negatively to the report. Deutsche Bank and Citi both downgraded the stock on 2026-05-06 and cut targets, citing slower earnings recovery and weaker margin assumptions. Hedge funds are selling aggressively, up 252.5% over the last quarter. Technical trend and modeled price-path probabilities also point lower.
Latest quarter: Q1 2026. Revenue rose 7.54% YoY to $8.504B, which is positive for growth. However, profitability deteriorated sharply: net income fell to -$266M, EPS dropped to -0.15, and gross margin declined to 27.01%. For a long-term buyer, the main issue is that growth is continuing but earnings quality and margins are still under pressure, so the recovery is incomplete.
Analyst sentiment has weakened recently. On 2026-05-06, Deutsche Bank downgraded CPNG to Hold from Buy and cut its target to $23 from $25, while Citi downgraded it to Neutral from Buy and cut its target to $22.20 from $23, citing a slower-than-expected earnings recovery after the Q1 miss. Earlier, Barclays had been more constructive and raised its target to $30 before earnings, and several firms still had overweight/buy views, but the latest revisions show the trend is turning more cautious. Wall Street pros are split: bulls still point to long-term scale, fulfillment advantages, and recovery potential, while bears emphasize margin compression, weaker EBITDA outlook, and post-breach uncertainty.
